These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
232 related items for PubMed ID: 31402164
1. Dimethylarginine dimethylaminohydrolase 1 deficiency aggravates monocrotaline-induced pulmonary oxidative stress, pulmonary arterial hypertension and right heart failure in rats. Wang D, Li H, Weir EK, Xu Y, Xu D, Chen Y. Int J Cardiol; 2019 Nov 15; 295():14-20. PubMed ID: 31402164 [Abstract] [Full Text] [Related]
2. Cardiomyocyte dimethylarginine dimethylaminohydrolase-1 (DDAH1) plays an important role in attenuating ventricular hypertrophy and dysfunction. Xu X, Zhang P, Kwak D, Fassett J, Yue W, Atzler D, Hu X, Liu X, Wang H, Lu Z, Guo H, Schwedhelm E, Böger RH, Chen P, Chen Y. Basic Res Cardiol; 2017 Aug 17; 112(5):55. PubMed ID: 28819685 [Abstract] [Full Text] [Related]
6. Involvement of asymmetric dimethylarginine and Rho kinase in the vascular remodeling in monocrotaline-induced pulmonary hypertension. Li XH, Peng J, Tan N, Wu WH, Li TT, Shi RZ, Li YJ. Vascul Pharmacol; 2010 May 31; 53(5-6):223-9. PubMed ID: 20840872 [Abstract] [Full Text] [Related]
7. Cardiomyocyte dimethylarginine dimethylaminohydrolase1 attenuates left-ventricular remodeling after acute myocardial infarction: involvement in oxidative stress and apoptosis. Hou L, Guo J, Xu F, Weng X, Yue W, Ge J. Basic Res Cardiol; 2018 Jun 11; 113(4):28. PubMed ID: 29892894 [Abstract] [Full Text] [Related]
8. Copaiba Oil Attenuates Right Ventricular Remodeling by Decreasing Myocardial Apoptotic Signaling in Monocrotaline-Induced Rats. Campos-Carraro C, Turck P, de Lima-Seolin BG, Tavares AMV, Dos Santos Lacerda D, Corssac GB, Teixeira RB, Hickmann A, Llesuy S, da Rosa Araujo AS, Belló-Klein A. J Cardiovasc Pharmacol; 2018 Nov 11; 72(5):214-221. PubMed ID: 30212415 [Abstract] [Full Text] [Related]
9. Analyses of long non-coding RNA and mRNA profiles in right ventricle myocardium of acute right heart failure in pulmonary arterial hypertension rats. Cao Y, Yang Y, Wang L, Li L, Zhang J, Gao X, Dai S, Zhang Y, Guo Q, Peng YG, Wang E. Biomed Pharmacother; 2018 Oct 11; 106():1108-1115. PubMed ID: 30119177 [Abstract] [Full Text] [Related]
10. Fischer rats exhibit maladaptive structural and molecular right ventricular remodelling in severe pulmonary hypertension: a genetically prone model for right heart failure. Suen CM, Chaudhary KR, Deng Y, Jiang B, Stewart DJ. Cardiovasc Res; 2019 Mar 15; 115(4):788-799. PubMed ID: 30357319 [Abstract] [Full Text] [Related]
12. Dimethylarginine dimethylaminohydrolase 1 protects PM2.5 exposure-induced lung injury in mice by repressing inflammation and oxidative stress. Gao J, Lei T, Wang H, Luo K, Wang Y, Cui B, Yu Z, Hu X, Zhang F, Chen Y, Ding W, Lu Z. Part Fibre Toxicol; 2022 Oct 14; 19(1):64. PubMed ID: 36242005 [Abstract] [Full Text] [Related]
14. Oxymatrine prevents the development of monocrotaline-induced pulmonary hypertension via regulation of the NG, NG-dimethyl-L-arginine metabolism pathways in rats. Dai G, Li B, Xu Y, Zeng Z, Yang H. Eur J Pharmacol; 2019 Jan 05; 842():338-344. PubMed ID: 30419238 [Abstract] [Full Text] [Related]
15. Upregulation of DDAH2 Limits Pulmonary Hypertension and Right Ventricular Hypertrophy During Chronic Hypoxia in Ddah1 Knockout Mice. Hannemann J, Glatzel A, Hillig J, Zummack J, Schumacher U, Lüneburg N, Harbaum L, Böger R. Front Physiol; 2020 Jan 05; 11():597559. PubMed ID: 33281630 [Abstract] [Full Text] [Related]
16. Impact of dietary iron restriction on the development of monocrotaline-induced pulmonary vascular remodeling and right ventricular failure in rats. Naito Y, Hosokawa M, Hao H, Sawada H, Hirotani S, Iwasaku T, Okuhara Y, Eguchi A, Hirota S, Ohyanagi M, Tsujino T, Masuyama T. Biochem Biophys Res Commun; 2013 Jun 28; 436(2):145-51. PubMed ID: 23707944 [Abstract] [Full Text] [Related]
18. Loss of KCNK3 is a hallmark of RV hypertrophy/dysfunction associated with pulmonary hypertension. Lambert M, Boet A, Rucker-Martin C, Mendes-Ferreira P, Capuano V, Hatem S, Adão R, Brás-Silva C, Hautefort A, Michel JB, Dorfmuller P, Fadel E, Kotsimbos T, Price L, Jourdon P, Montani D, Humbert M, Perros F, Antigny F. Cardiovasc Res; 2018 May 01; 114(6):880-893. PubMed ID: 29360952 [Abstract] [Full Text] [Related]
19. Contribution of Impaired Parasympathetic Activity to Right Ventricular Dysfunction and Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension. da Silva Gonçalves Bós D, Van Der Bruggen CEE, Kurakula K, Sun XQ, Casali KR, Casali AG, Rol N, Szulcek R, Dos Remedios C, Guignabert C, Tu L, Dorfmüller P, Humbert M, Wijnker PJM, Kuster DWD, van der Velden J, Goumans MJ, Bogaard HJ, Vonk-Noordegraaf A, de Man FS, Handoko ML. Circulation; 2018 Feb 27; 137(9):910-924. PubMed ID: 29167228 [Abstract] [Full Text] [Related]